Monteris Adds New Trial Data To Its Case For A New-Tech Payment

Monteris Medical CEO Jim Duncan shared data from a first-in-man study of the firm's AutoLITT tumor ablation catheter during a Feb. 19 new-technology town hall meeting at CMS headquarters in Baltimore